GSK, Daiichi Sankyo Dissolve Vaccine JV

November 14, 2018
Daiichi Sankyo and the Japan arm of GlaxoSmithKline said on November 14 that they have agreed to dissolve their joint venture, Japan Vaccine, noting the date of the dissolution and detailed transition plans to be announced later. Founded in 2012,...read more